Congress Trades

IDXXIDEXX Laboratories, Inc.

Healthcare · Diagnostics & ResearchNasdaqStockMkt cap $41.6B
Disclosed trades
29
0 in 30d · 0 in 90d
Politicians
7
Last trade Jan 13, 2026
Buys
15
$211.5K at range midpoints
Sells
14
$279K at range midpoints

Closing price · 365 days

Sep 24, 2025 – Sep 23, 2026

Monthly buys vs sells · 24 months

Counts of disclosed transactions
  • Buys
  • Sells (incl. partial)

Politicians who traded it

Politicians who traded IDXX
PoliticianSeatTradesBuysSellsBought (mid)Sold (mid)Last trade
DApril McClain DelaneyHouse · MD-061257$40K$56KJan 13, 2026
RTommy TubervilleSenate · AL532$24K$16KJan 22, 2024
DGilbert Ray Cisneros, Jr.House · CA-31312$8K$16KOct 9, 2020
RJefferson ShreveHouse · IN-06321$107.5K$175KMay 12, 2025
RRobert P. Bresnahan, Jr.House · PA-08321$16K$8KMay 15, 2025
RByron DonaldsHouse · FL-19220$16K$0Sep 4, 2025
RPeter MeijerHouse · MI-03101$0$8KFeb 16, 2021

Recent trades

Disclosed trades
PoliticianTickerAssetTypeOwnerAmountTradedFiledSource
DApril McClain DelaneyIDXXIDEXX Laboratories, Inc. - Common Stock (IDXX)SellDependent$1,001 - $15,000Jan 13, 2026Feb 2, 202620dFiling
DApril McClain DelaneyIDXXIDEXX Laboratories, Inc. - Common Stock (IDXX)PartialDependent$1,001 - $15,000Dec 2, 2025Jan 5, 202634dFiling
DApril McClain DelaneyIDXXIDEXX Laboratories, Inc. - Common Stock (IDXX)PartialDependent$1,001 - $15,000Oct 29, 2025Nov 4, 20256dFiling
DApril McClain DelaneyIDXXIDEXX Laboratories, Inc. - Common Stock (IDXX)PartialDependent$1,001 - $15,000Oct 16, 2025Nov 4, 202519dFiling
RByron DonaldsIDXXIDEXX Laboratories, Inc. - Common Stock (IDXX)BuySpouse$1,001 - $15,000Sep 4, 2025Oct 7, 202533dFiling
RByron DonaldsIDXXIDEXX Laboratories, Inc. - Common Stock (IDXX)BuySelf$1,001 - $15,000Sep 4, 2025Oct 7, 202533dFiling
DApril McClain DelaneyIDXXIDEXX Laboratories, Inc. - Common Stock (IDXX)PartialDependent$1,001 - $15,000Aug 7, 2025Sep 2, 202526dFiling
DApril McClain DelaneyIDXXIDEXX Laboratories, Inc. - Common Stock (IDXX)PartialDependent$1,001 - $15,000Aug 1, 2025Sep 2, 202532dFiling
DApril McClain DelaneyIDXXIDEXX Laboratories, Inc. - Common Stock (IDXX)PartialDependent$1,001 - $15,000Jul 9, 2025Aug 5, 202527dFiling
RJefferson ShreveIDXXIDEXX Laboratories, Inc. - Common Stock (IDXX)SellSelf$100,001 - $250,000May 12, 2025Jun 22, 202541dFiling
RRobert P. Bresnahan, Jr.IDXXIDEXX Laboratories, Inc. - Common Stock (IDXX)BuySelf$1,001 - $15,000May 15, 2025Jun 9, 202525dFiling
RJefferson ShreveIDXXIDEXX Laboratories, Inc. - Common Stock (IDXX)BuySelf$50,001 - $100,000Apr 7, 2025May 8, 202531dFiling
DApril McClain DelaneyIDXXIDEXX Laboratories, Inc. - Common Stock (IDXX)BuyDependent$1,001 - $15,000Apr 9, 2025May 2, 202523dFiling
DApril McClain DelaneyIDXXIDEXX Laboratories, Inc. - Common Stock (IDXX)BuyDependent$1,001 - $15,000Apr 7, 2025May 2, 202525dFiling
DApril McClain DelaneyIDXXIDEXX Laboratories, Inc. - Common Stock (IDXX)BuyDependent$1,001 - $15,000Apr 4, 2025May 2, 202528dFiling
DApril McClain DelaneyIDXXIDEXX Laboratories, Inc. - Common Stock (IDXX)BuyDependent$1,001 - $15,000Apr 1, 2025May 2, 202531dFiling
RRobert P. Bresnahan, Jr.IDXXIDEXX Laboratories, Inc. - Common Stock (IDXX)SellSelf$1,001 - $15,000Apr 8, 2025Apr 28, 202520dFiling
RJefferson ShreveIDXXIDEXX Laboratories, Inc. - Common Stock (IDXX)BuySelf$15,001 - $50,000Mar 13, 2025Apr 11, 202529dFiling
DApril McClain DelaneyIDXXIDEXX Laboratories, Inc. - Common Stock (IDXX)BuyDependent$1,001 - $15,000Mar 14, 2025Apr 2, 202519dFiling
RRobert P. Bresnahan, Jr.IDXXIDEXX Laboratories, Inc. - Common Stock (IDXX)BuySelf$1,001 - $15,000Feb 25, 2025Mar 27, 202530dFiling
RTommy TubervilleIDXXIDEXX Laboratories, Inc. - Common StockSellJoint$1,001 - $15,000Jan 22, 2024Feb 14, 202423dFiling
RTommy TubervilleIDXXIDEXX Laboratories, Inc. - Common StockBuyJoint$1,001 - $15,000Apr 3, 2023May 12, 202339dFiling
RTommy TubervilleIDXXIDEXX Laboratories, Inc. - Common StockBuyJoint$1,001 - $15,000Apr 3, 2023May 11, 202338dFiling
RTommy TubervilleIDXXIDEXX Laboratories, Inc. - Common StockSellJoint$1,001 - $15,000Oct 5, 2022Nov 10, 202236dFiling
RTommy TubervilleIDXXIDEXX Laboratories, Inc.BuyJoint$1,001 - $15,000Mar 29, 2021Jul 23, 2021116dFiling
RPeter MeijerIDXXIdEXX laboratories, Inc. (IdXX)SellSelf$1,001 - $15,000Feb 16, 2021Mar 16, 202128dFiling
DGilbert Ray Cisneros, Jr.IDXXIdEXX Laboratories, Inc. (IdXX)PartialSelf$1,001 - $15,000Oct 9, 2020Nov 5, 202027dFiling
DGilbert Ray Cisneros, Jr.IDXXIdEXX Laboratories, Inc. (IdXX)PartialSelf$1,001 - $15,000Jun 10, 2020Jul 17, 202037dFiling
DGilbert Ray Cisneros, Jr.IDXXIdEXX Laboratories, Inc. (IdXX)BuySelf$1,001 - $15,000Apr 9, 2020May 13, 202034dFiling

Insider activity Filed

Insiders
24
In Vitro & In Vivo Diagnostic Substances
Open-market buys · 90d
0
$0 bought
Open-market sells · 90d
1
$1.2M sold
Net · 90d
-$1.2M
-$37.7M net over 12 months · last Sep 4, 2026
Insider transactions as filed on SEC Form 4
DateInsiderKindSecuritySharesPriceValuePost-holdingsD/I10b5-1Source
Sep 4, 2026filed Sep 9, 2026Lawrence D KingsleyExerciseNon-Qualified Stock Option (right-to-buy)deriv.−2,203——0D—4
Sep 4, 2026filed Sep 9, 2026Lawrence D KingsleySaleCommon Stock−2,203$532.08$1,172,1789,568D—4
Sep 4, 2026filed Sep 9, 2026Lawrence D KingsleyExerciseCommon Stock2,203$114.17$251,51711,771D—4
Aug 20, 2026filed Aug 24, 2026Andrew EmersonEVP, CFO and TreasurerExerciseIncentive Stock Option (right-to-buy)deriv.−265——925D—4
Aug 20, 2026filed Aug 24, 2026Andrew EmersonEVP, CFO and TreasurerWithholdingCommon Stock−86$0.00$04,421.44D—4
Aug 20, 2026filed Aug 24, 2026Andrew EmersonEVP, CFO and TreasurerExerciseCommon Stock265$178.26$47,2394,507.44D—4
Jul 30, 2026filed Aug 3, 2026Joseph L HooleyAwardCommon Stock49$558.80$27,381325D—4
Jun 1, 2026filed Jun 2, 2026George FennellExecutive Vice PresidentExerciseRestricted Stock Unitderiv.−639——0D—4
Jun 1, 2026filed Jun 2, 2026George FennellExecutive Vice PresidentWithholdingCommon Stock−284$566.79$160,96810,433D—4
Jun 1, 2026filed Jun 2, 2026George FennellExecutive Vice PresidentExerciseCommon Stock639$0.00$010,717D—4

Shares, prices and post-transaction holdings are exactly as reported on SEC Form 4. Net figures count open-market buys minus open-market sales only (awards, exercises, withholding and gifts are excluded).

Unusual activity Estimated